Application to the Bulgarian Drug Agency
R&D
January 2018 CMDh/226/2007 Rev.5 <Applicant> <Address> <Address> <Post code> <Town> <Country>
European Reference Product - questions and answers
Biologics | Free Full-Text | The Coming of Age of Biosimilars: A Personal Perspective
Untitled
External Representation - EURORDIS
Biosimilar medicines: Overview | European Medicines Agency
Book 4C: 2022 Good Manufacturing Practice in the European Union, Refer – Clinical Research Resources, LLC
Procedures for the Authorisation of Veterinary Medicinal Products
Biosimilar medicines: marketing authorisation | European Medicines Agency
Reference pricing systems in Europe: characteristics and - GaBI Journal
Different roles of the EDQM and the EMA for regulation of herbal... | Download Scientific Diagram
Towards a Urological European Reference Network: Share, Care and Cure - Uroweb
Access to medicinal products
The Italian Medicines Agency provides additional information on the new simplified classification procedure for generics and biosimilars - Portolano Cavallo
The EU is ready for non-biological complex medicinal products - GaBI Journal
Market Authorization of Biological Medicinal Products in EU
Innovator Selection (Reference Medicinal Product) by Mr. Pankaj Dhapa…
Marketing authorization and licensing of medicinal products in EU: Regulatory aspects - ScienceDirect
Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review - The Lancet Regional Health – Europe
CMD(h) WORKING DOCUMENT - INFORMATION TO BE SUBMITTED BY THE MEMBER STATE OF THE EUROPEAN REFERENCE MEDICINAL PRODUCT January 20
Marketing authorisations which are recommended for maintenance and marketing authorisation applications for which bioequivalence
The european substance reference system (EU - SRS) release strategy widely supported by the community - UNICOM
Reference medicinal products by michelle.gafa
